1 / 125

Cutaneous Manifestations of Systemic Diseases

Cutaneous Manifestations of Systemic Diseases. Hayden H. Franks, MD June 13, 2013. Who Is This Guy?. Private practice Dermatologist Clinics in Little Rock and Texarkana Fellow of the American Academy of Dermatology Diplomate of the American Board of Dermatology

zahina
Télécharger la présentation

Cutaneous Manifestations of Systemic Diseases

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Cutaneous Manifestations of Systemic Diseases Hayden H. Franks, MD June 13, 2013

  2. Who Is This Guy? • Private practice Dermatologist • Clinics in Little Rock and Texarkana • Fellow of the American Academy of Dermatology • Diplomate of the American Board of Dermatology • Assistant Clinical Professor of Dermatology, UAMS AHEC SW • Honorary Member of the Arkansas Academy of Family Physicians

  3. Disease Categories • Autoimmune Diseases • Endocrine Diseases • Cardiopulmonary Diseases • Gastrointestinal Diseases • Neurological Diseases • Diseases not Otherwise Specifiied

  4. Cutaneous Manifestations of Systemic Diseases • Frequently encountered • May be the initial sign of internal disease • May occur late in the course of the disease • May assist in making the diagnosis • May be obvious or subtle • Overlap of Family Practice and Dermatology

  5. AUTOIMMUNE DISEASES • Systemic Lupus Erythematosus • Scleroderma • Dermatomyositis • Rheumatoid Arthritis

  6. Systemic Lupus Erythematosus • Autoimmune, systemic disease affecting multiple organ systems • The most common connective tissue disease • Especially prevalent in black women – Prevalence 1/250 • Cutaneous lesions present in 85% of patients • Of the 11 Classic Criteria for diagnosing SLE, 4 involve the skin or mucus membranes

  7. Systemic Lupus Erythematosus • Malar (Butterfly) rash is the “classic presentation” • May be distinct or subtle

  8. Systemic Lupus Erythematosus • Fixed erythema, flat or raised, over malar eminences • Spares the Nasolabial Folds

  9. Systemic Lupus Erythematosus • Discoid Rash is “classic” as well

  10. Systemic Lupus Erythematosus • Erythematous, patches and plaques, with adherent scales, follicular plugging and atrophic scarring

  11. Systemic Lupus Erythematosus • Photosensitivity – rash as an unusual reaction to sunlight

  12. Systemic Lupus Erythematosus • Oral Ulcers – usually painless and may be nasopharyngeal

  13. Systemic Lupus Erythematosus • Presentation isn’t always “classic” • High index of suspicion • Alopecia and rash may be anywhere on skin

  14. Systemic Lupus Erythematosus • Diagnosis is based on presence of multisystem disease and presence of antinuclear antibodies • Treatment is multifactorial with corticosteroids being the mainstay still • Sunscreen • Antimalarials, methotrexate, dapsone and biologics now are commonly used

  15. Scleroderma • Chronic autoimmune disease of unknown cause that affects the microvasculature and loose connective tissue • Characterized by fibrosis and obliteration of vessels in skin, lungs, GI tract, kidneys and heart • May be localized (Morphea) or systemic (Systemic Scleroderma)

  16. Scleroderma (Morphea) • Morphea – benign and self limited • Usually single or few in number • Red, then white, atrophic, indurated with alopecia

  17. Scleroderma (Morphea) • Treatment is unsatisfactory • Topical or intralesional steroids, PUVA

  18. Systemic Scleroderma (SSc) • Four times more common in women • 10 year survival rate of 21-71% • Clinical manifestations depend on the sites involved • Initial complaints are usually Raynaud’s phenomenon or chronic, non pitting edema of hands and fingers or migratory polyarthritis • Disease may extend to involve upper extremities, trunk, face and finally the lower extremities

  19. Systemic Scleroderma (SSc)

  20. Systemic Scleroderma (SSc)

  21. Systemic Scleroderma (SSc)

  22. Systemic Scleroderma (SSc) Diagnosis • Autoantibodies to Fibrillin 1, Rheumatoid Factor, Anti SS DNA, Anti RNA Polymerase 3, Antitopoisomerase 1, Anticentromere Antibodies • Skin Biopsy

  23. Systemic Scleroderma (SSc) Treatment • Treatment is unsatisfactory • Immunosuppressive Drugs of numerous types • Methotrexate, Cyclosporine, Imuran • Biologics

  24. Dermatomyositis • The most common idiopathic inflammatory myopathy • May occur at any age • Unknown etiology • Autoimmune Disease • Progressive weakness of trunk and major limb muscles • Difficulty in rising from a chair or climbing stairs • Impaired mobility and some muscle tenderness

  25. Dermatomyositis • Bilateral muscle weakness that is progressive • Skin lesions are almost always present from the onset • Maculopapularerythema over bony prominences such as the knuckles, elbows and knees • Red to violaceous plaques with telangiectasias and scales • Gottron’s Papules – polymorphic, erythematous and atrophic plaques

  26. Dermatomyositis

  27. Dermatomyositis

  28. Dermatomyositis • Heliotrope Rash – Periorbitalerythema • Nail Margin Telangiectasias

  29. Dermatomyositis Diagnosis • Elevated serum muscle enzymes (CK) and Aldolase • Antinuclear Antibodies • Muscle biopsy – segmental muscle fiber fibrosis, interstitial inflammation and vasculopathy • Skin biopsy – Focal vacuolar degeneration of basal cells, basement membrane degeneration and epidermal atrophy

  30. Dermatomyositis Treatment • Primary treatment remains Prednisone 1mg/kg/day • Plasmapheresis • Cyclosporine • Dapsone • ?Biologics • Physical Therapy

  31. Rheumatoid Arthritis • Disease affects up to 2% of adult women • Onset is sudden or insidious • Symmetric polyarthritis that affects the proximal interphalangeal and metacarpophalangeal joints, the wrists, ankles, knees and cervical spine • Stiffness, painful, warm and tender joints • Fever, weight loss and anemia are prominent

  32. Rheumatoid Arthritis • Rheumatoid Nodules – discrete, non tender subcutaneous tumors

  33. Rheumatoid Arthritis • Vascular Lesions – erythema of palms and digital infarcts

  34. Rheumatoid Arthritis

  35. Rheumatoid Arthritis • Gravitational ulcers – most common • Arteritic ulcers – actually rare until advanced disease

  36. Rheumatoid Arthritis • Laboratory Workup – Rheumatoid Factor and ANA • Treatment – Prednisone, Methotrexate, Biologics

  37. ENDOCRINE DISEASES • Diabetes Mellitus • Thyroid Disease

  38. Diabetes Mellitus • The skin shares both in the effects of acute metabolic derangements and in the chronic degenerative complications of diabetes.

  39. Diabetes Mellitus • Infection • Diabetic Dermopathy • Thickened skin, stiff joints and ScleredemaAdultorum • NecrobiosisLipoidicaDiabeticorum • Vitiligo • AcanthosisNigricans • Kyrle’s Disease (Reactive Perforating Collagenosis)

  40. Diabetes Mellitus • Bacterial and fungal infections • Furunculosis, Cellulitis, Erythrasma, and Candidiasis • Hyperglycemia leads to abnormalities in leukocyte function including diminished chemotaxis and phagocytosis

  41. Diabetes Mellitus • Bacterial Infections

  42. Diabetes Mellitus • Cellulitis

  43. Diabetes Mellitus • Erythrasma

  44. Diabetes Mellitus • Candidiasis

  45. Diabetes Mellitus • Diabetic Dermopathy – atrophic, circumscribed brownish lesions usually on the lower extremities • They resemble post traumatic scarring

  46. Diabetes Mellitus • Thickened Skin, Stiff Joints and ScleredemaAdultorum • 33% of Diabetics have tight, indurated and waxy skin over the dorsa of the hands • ScleredemaAdultorum is strongly correlated with IDDM • Consists of induration of the skin beginning on the posterior and lateral aspect of the neck, is painless and may be progressive

  47. Diabetes Mellitus

  48. Diabetes Mellitus • ScleredemaAdultorum

  49. Diabetes Mellitus • NecrobiosisLipoidicaDiabeticorum • Occurs in 0.3% of IDDM Patients • Very distinct • Asymptomatic, atrophic, yellow to brown patches classically on the lower extremities • Telangiectasias are prominent

  50. Diabetes Mellitus • NecrobiosisLipoidicaDiabeticorum

More Related